Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/20.500.12008/54554

Título:

Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections

Otros títulos:

Coordinador:

Director:

Compilador:

Autor:

Basiletti, Jorge Alejandro
Valls, Joan
Poklépovich, Tomás
Fellner, María Dolores
Rol, Maryluz
Alonso, Rafael
Correa, Rita Mariel
Colucci, María Celeste
Rodríguez de la Peña, Mercedes
Falabella, Paula Gabriela
Saíno, Agustina
Campos, Josefina
Herrero, Rolando
Almonte, Maribel
Picconi, María Alejandra

Tutor:

Tipo de documento:

Artículo

Editor:

Palabras clave:

Descriptores:

VIRUS DEL PAPILOMA HUMANO
INFECCIONES POR PAPILLOMAVIRUS
GENOTIPO
VACUNAS CONTRA PAPILLOMAVIRUS
SECUENCIACIÓN DE NUCLEÓTIDOS DE ALTO RENDIMIENTO
TÉCNICAS GENÉTICAS
ANÄLISIS DE SECUENCIA

Año de publicación:

2022

Contenido:

Resumen:

Sensitive and specific genotyping of human papillomaviruses (HPVs) is critical for the surveillance and monitoring of the vaccine effectiveness. Here, HPV genotypes were identified in 137 cervical samples with different histology (79 ≤CIN1 and 58 CIN3+) using Nested-PCR followed by Next-Generation sequencing (NGS) and relative proportions for each genotype in multiple infections were computed. All samples had been previously genotyped by PCR-Reverse Blotting Hybridization (PCR-RBH) thus allowing for a concordance analysis between both techniques. Multiple infections were present in 85% of ≤CIN1 cases compared to only 41% in CIN3+ cases (p<0.001). Among ≤CIN1 cases a towering genotypic diversity was observed, considering both low (LR-) and high risk (HR-) HPV genotypes; while among CIN3+, diversity was lower, HR-HPVs prevailing in most cases, especially HPV16. Furthermore, the predominance of HR-HPV genotypes in the proportions identified in each sample was higher in CIN3+ cases [(HPV16 (62.5%), followed by HPV31 and HPV58 (8.3% each)], than in ≤CIN1 cases [(HPV16 (17.7%), followed by HPV52 (14.7%) and HPV31 (10.3%)]. Agreement between PCR-RBH and NGS was higher than 90% for all genotypes (with an overall Kappa of 0.7), even though NGS identified eighty-nine positive results for HPV genotypes that had not been detected by PCR-RBH, evidencing its greater sensitivity. These results suggest that a reduction in genotypic diversity and/or an increase in the relative proportion of HR-HPVs in multiple infections can be considered as a biomarker for the potential risk of malignant progression.

Descripción:

metadata.articulos.dc.description.uri:

Editorial:

Public Library of Science

EN:

PLoS ONE. 2022;17(11)

Financiadores:

Citación:

Basiletti J, Valls J, Poklépovich T y otros. Human papillomavirus genotyping using next generation sequencing (NGS) in cervical lesions: Genotypes by histologic grade and their relative proportion in multiple infections. PLoS ONE [en línea]. 2022;17(11). 16 p.

Citación:

metadata.articulos.cc.license.name:

ISBN:

e-ISBN:

ISSN:

ISMN:

Otros identificadores:

Cobertura geográfica:

Cobertura temporal:

Departamento académico:

Grupo de investigación:

Licencia:

Licencia Creative Commons Atribución (CC - By 4.0)

Colecciones:

Publicaciones Académicas y Científicas
FicherosDescripciónTamañoFormato
Humanpapillomavirus genotyping.pdf Humanpapillomavirus genotyping 1.15 MB Adobe PDF
Mostrar el registro Dublin Core completo del ítem